MA38948A1 - Dérivés de 2h-indazole antibactériens - Google Patents
Dérivés de 2h-indazole antibactériensInfo
- Publication number
- MA38948A1 MA38948A1 MA38948A MA38948A MA38948A1 MA 38948 A1 MA38948 A1 MA 38948A1 MA 38948 A MA38948 A MA 38948A MA 38948 A MA38948 A MA 38948A MA 38948 A1 MA38948 A1 MA 38948A1
- Authority
- MA
- Morocco
- Prior art keywords
- antibacterial
- indazole derivatives
- halogen
- indazole
- derivatives
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title abstract 2
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical class C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 title 1
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000005133 alkynyloxy group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/65031—Five-membered rings having the nitrogen atoms in the positions 1 and 2
- C07F9/65038—Five-membered rings having the nitrogen atoms in the positions 1 and 2 condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne des composés antibactériens de formule (i) dans laquelle r1 est h ou halogène; r2 est alkynyloxy ou le groupe m; r3 est h ou halogène; m est un parmi les groupes (a, b, c, d) dans lequel a est une liaison, ch2 ch2, ch=ch ou c=c et r1a, r2a, r3a, r1b et r1c sont tels que définis dans la revendication 1; et des sels de ceux-ci.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2013058537 | 2013-09-13 | ||
| PCT/IB2014/064458 WO2015036964A1 (fr) | 2013-09-13 | 2014-09-12 | Dérivés de 2h-indazole antibactériens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA38948A1 true MA38948A1 (fr) | 2017-05-31 |
| MA38948B1 MA38948B1 (fr) | 2018-04-30 |
Family
ID=51688371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA38948A MA38948B1 (fr) | 2013-09-13 | 2014-09-12 | Dérivés de 2h-indazole antibactériens |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US9802901B2 (fr) |
| EP (1) | EP3044211B1 (fr) |
| JP (1) | JP6353909B2 (fr) |
| KR (1) | KR20160055889A (fr) |
| CN (1) | CN105531264B (fr) |
| AR (1) | AR097617A1 (fr) |
| AU (1) | AU2014319966B2 (fr) |
| BR (1) | BR112016007757A8 (fr) |
| CA (1) | CA2923146A1 (fr) |
| CL (1) | CL2016000568A1 (fr) |
| CY (1) | CY1120111T1 (fr) |
| DK (1) | DK3044211T3 (fr) |
| EA (1) | EA031562B1 (fr) |
| ES (1) | ES2662894T3 (fr) |
| HR (1) | HRP20180484T1 (fr) |
| HU (1) | HUE038519T2 (fr) |
| IL (1) | IL244500B (fr) |
| LT (1) | LT3044211T (fr) |
| MA (1) | MA38948B1 (fr) |
| MX (1) | MX361733B (fr) |
| MY (1) | MY179283A (fr) |
| PH (1) | PH12016500480A1 (fr) |
| PL (1) | PL3044211T3 (fr) |
| PT (1) | PT3044211T (fr) |
| SG (1) | SG11201601889YA (fr) |
| SI (1) | SI3044211T1 (fr) |
| TW (1) | TWI646084B (fr) |
| UA (1) | UA116484C2 (fr) |
| WO (1) | WO2015036964A1 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA030730B1 (ru) | 2013-12-19 | 2018-09-28 | Идорсиа Фармасьютиклз Лтд | Антибактериальные производные 1h-индазола и 1h-индола |
| AR099612A1 (es) | 2014-03-04 | 2016-08-03 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona |
| MX2016014989A (es) | 2014-05-16 | 2017-03-31 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos de quinazolina-4 (3h)-ona. |
| CA2963875A1 (fr) | 2014-11-19 | 2016-05-26 | Actelion Pharmaceuticals Ltd | Derives de benzothiazole antibacteriens |
| AR105646A1 (es) * | 2015-08-11 | 2017-10-25 | Actelion Pharmaceuticals Ltd | Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida |
| CN107922433A (zh) * | 2015-08-28 | 2018-04-17 | 爱杜西亚药品有限公司 | 抗菌环化吡咯烷‑2‑酮衍生物 |
| AR105848A1 (es) * | 2015-08-31 | 2017-11-15 | Actelion Pharmaceuticals Ltd | Derivados heterocíclicos antibacterianos |
| AR105889A1 (es) * | 2015-09-03 | 2017-11-22 | Actelion Pharmaceuticals Ltd | Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos |
| CA3024756A1 (fr) * | 2016-05-17 | 2017-11-23 | Idorsia Pharmaceuticals Ltd | Derives de 6-(buta-1,3-diyn-1-yl)benzo [d] thiazole |
| WO2019038362A1 (fr) | 2017-08-24 | 2019-02-28 | Idorsia Pharmaceuticals Ltd | Pyrroloimidazolones antibactériennes |
| CN113372276B (zh) * | 2021-05-25 | 2022-04-22 | 三峡大学 | 吲唑类衍生物及其应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0500018A3 (en) | 2001-12-05 | 2009-09-28 | Ortho Mcneil Pharm Inc | 6-o-acyl ketolide derivatives of erythromycine processes for preparing them and using them as antibacterials |
| US6806279B2 (en) | 2001-12-17 | 2004-10-19 | Sunesis Pharmaceuticals, Inc. | Small-molecule inhibitors of interleukin-2 |
| ES2549159T3 (es) | 2002-03-13 | 2015-10-23 | Array Biopharma, Inc. | Derivados de bencimidazol N3-alquilados como inhibidores de MEK |
| DE102004017930A1 (de) | 2004-04-14 | 2005-11-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel |
| BRPI0518984A2 (pt) | 2004-12-10 | 2008-12-16 | Univ Emory | anÁlogos de nucleosÍdeo de ciclobutil substituÍdos em 2' e 3' para tratamento de infecÇÕes virais e proliferaÇço celular anormal |
| BRPI0609719B8 (pt) | 2005-03-23 | 2021-05-25 | Hoffmann La Roche | derivados de acetilenil-pirazol-pirimidina como antagonistas de mgbur2 |
| TWI519508B (zh) | 2007-06-12 | 2016-02-01 | Achaogen Inc | 抗菌劑 |
| DE102008044132A1 (de) | 2008-11-27 | 2010-06-02 | BSH Bosch und Siemens Hausgeräte GmbH | Kältegerät mit zweiseitig anschlagbarer Tür |
| WO2010100475A1 (fr) | 2009-03-02 | 2010-09-10 | Astrazeneca Ab | Dérivés de l'acide hydroxamique en tant qu'agents contre des bactéries à gram négatif |
| EP2432468A2 (fr) | 2009-05-20 | 2012-03-28 | Ardea Biosciences, Inc. | Procédés pour moduler des taux d'acide urique |
| EP2451790A4 (fr) | 2009-07-07 | 2012-12-26 | Anthem Biosciences Private Ltd | Inhibiteurs de l histone désacétylase |
| JP5671545B2 (ja) * | 2009-10-13 | 2015-02-18 | ファイザー・インク | 抗菌薬として有用なｃ結合ヒドロキサム酸誘導体 |
| PL2512474T3 (pl) | 2009-12-16 | 2015-03-31 | Pfizer | N-przyłączone pochodne kwasu hydroksamowego użyteczne jako środki przeciwbakteryjne |
| GB2483736B (en) | 2010-09-16 | 2012-08-29 | Aragon Pharmaceuticals Inc | Estrogen receptor modulators and uses thereof |
| EP2638006A1 (fr) | 2010-11-10 | 2013-09-18 | Achaogen, Inc. | Dérivés d'acide hydroxamique et leur utilisation dans le traitement d'infections bactériennes |
| JP2014501274A (ja) | 2011-01-03 | 2014-01-20 | ハンミ ファーム． シーオー．， エルティーディー． | Ｇタンパク質共役受容体調節のための新規な二環式化合物 |
| UA107423C2 (en) * | 2011-03-07 | 2014-12-25 | Pfizer | Fluoro-pyridinone derivatives useful as antibacterial agents |
| DK2694488T3 (en) | 2011-04-08 | 2014-12-15 | Pfizer | Isoxazole derivatives useful as antibacterial SUBSTANCES |
| JP2014514299A (ja) * | 2011-04-08 | 2014-06-19 | ファイザー・インク | 抗菌剤として有用なイミダゾール、ピラゾールおよびトリアゾール誘導体 |
| EP2847162A1 (fr) | 2012-05-09 | 2015-03-18 | Achaogen, Inc. | Agents antibactériens |
| EA030730B1 (ru) | 2013-12-19 | 2018-09-28 | Идорсиа Фармасьютиклз Лтд | Антибактериальные производные 1h-индазола и 1h-индола |
| AR099612A1 (es) | 2014-03-04 | 2016-08-03 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona |
| MX2016014989A (es) | 2014-05-16 | 2017-03-31 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos de quinazolina-4 (3h)-ona. |
-
2014
- 2014-09-10 AR ARP140103376A patent/AR097617A1/es unknown
- 2014-09-12 MY MYPI2016700850A patent/MY179283A/en unknown
- 2014-09-12 SI SI201430662T patent/SI3044211T1/en unknown
- 2014-09-12 ES ES14781948.6T patent/ES2662894T3/es active Active
- 2014-09-12 BR BR112016007757A patent/BR112016007757A8/pt not_active Application Discontinuation
- 2014-09-12 DK DK14781948.6T patent/DK3044211T3/en active
- 2014-09-12 LT LTEP14781948.6T patent/LT3044211T/lt unknown
- 2014-09-12 PL PL14781948T patent/PL3044211T3/pl unknown
- 2014-09-12 US US15/021,649 patent/US9802901B2/en not_active Expired - Fee Related
- 2014-09-12 JP JP2016542426A patent/JP6353909B2/ja not_active Expired - Fee Related
- 2014-09-12 SG SG11201601889YA patent/SG11201601889YA/en unknown
- 2014-09-12 CA CA2923146A patent/CA2923146A1/fr not_active Abandoned
- 2014-09-12 CN CN201480049877.8A patent/CN105531264B/zh not_active Expired - Fee Related
- 2014-09-12 EP EP14781948.6A patent/EP3044211B1/fr not_active Not-in-force
- 2014-09-12 HU HUE14781948A patent/HUE038519T2/hu unknown
- 2014-09-12 TW TW103131666A patent/TWI646084B/zh not_active IP Right Cessation
- 2014-09-12 KR KR1020167009718A patent/KR20160055889A/ko not_active Application Discontinuation
- 2014-09-12 MA MA38948A patent/MA38948B1/fr unknown
- 2014-09-12 WO PCT/IB2014/064458 patent/WO2015036964A1/fr active Application Filing
- 2014-09-12 MX MX2016003196A patent/MX361733B/es active IP Right Grant
- 2014-09-12 AU AU2014319966A patent/AU2014319966B2/en not_active Ceased
- 2014-09-12 EA EA201600248A patent/EA031562B1/ru not_active IP Right Cessation
- 2014-09-12 PT PT147819486T patent/PT3044211T/pt unknown
- 2014-12-09 UA UAA201603879A patent/UA116484C2/uk unknown
-
2016
- 2016-03-08 IL IL244500A patent/IL244500B/en not_active IP Right Cessation
- 2016-03-10 CL CL2016000568A patent/CL2016000568A1/es unknown
- 2016-03-11 PH PH12016500480A patent/PH12016500480A1/en unknown
-
2018
- 2018-03-23 HR HRP20180484TT patent/HRP20180484T1/hr unknown
- 2018-03-30 CY CY20181100362T patent/CY1120111T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA38948B1 (fr) | Dérivés de 2h-indazole antibactériens | |
| MA39707B1 (fr) | Dérivés de 1,2-dihydro-3h-pyrrolo [1,2-c]imidazol-3-one et leur utilisation comme agents antibactériens | |
| CY1121549T1 (el) | Ενωσεις 1-αρυλκαρβονυλ-4-oξυ-πιπεριδινης χρησιμες για την αγωγη νευροεκφυλιστικων παθησεων | |
| MA37940A2 (fr) | Nouveaux dérivés bicycliques | |
| BRPI1009637A2 (pt) | composto, composição e uso de um composto | |
| EA201690019A1 (ru) | Производное аминотриазина и содержащая его фармацевтическая композиция | |
| EA201690153A1 (ru) | Замещенные бензофуранильные и бензоксазолильные соединения и их применения | |
| EA200970510A1 (ru) | Гетеромоноциклическое соединение и его применение | |
| MA37756A1 (fr) | Nouveaux composés diazaspirocycloalcane et azaspirocycloalcane | |
| CY1120477T1 (el) | Ενεργοποιητης του υποδοχεα που ενεργοποιειται απο πολλαπλασιαστες των υπεροξεισωματων | |
| CY1113989T1 (el) | Ρυθμιστες 2,3-διοξυγενασης ινδολοαμινης και μεθοδοι χρησης αυτων | |
| AR072016A1 (es) | Derivados de isoxazol que funcionan como potenciadores de los receptores de glutamato | |
| MA35434B1 (fr) | Amino-quinazolines en tant qu'inhibiteurs de kinase | |
| PE20141553A1 (es) | Compuestos de triazolopiridina como inhibidores de la ped10a | |
| MA39152B1 (fr) | Cyclopentanes substitués en 1,2 utilisés comme antagonistes du récepteur d'orexine | |
| BR112016026787A8 (pt) | Derivados de quinzaolina-4(3h)-ona antibacterianos | |
| MA39315A1 (fr) | Dérivés de pyridazine à utiliser dans la prévention ou le traitement d'un trouble ataxique | |
| NZ746906A (en) | Oxaborole esters and uses thereof | |
| BR112015027164A2 (pt) | novos compostos com tripla atividade de trombólise, antitrombótica e neutralização de radical, e sua síntese, nanoestrutura e uso | |
| MX2016006763A (es) | Inhibidores de tirosina cinasa de bruton. | |
| MX2016006744A (es) | Inhibidores de tirosina cinasa de bruton. | |
| MA39305A3 (fr) | Dérivés d'éthynyle | |
| NO20080553L (no) | Azinyl-3-sulfonylindazolderivater som 5-hydroksytrypyamin-6 ligander | |
| MX2016006351A (es) | Inhibidores de tirosina cinasa de bruton. | |
| EA200971003A1 (ru) | Бициклическое соединение и его фармацевтическое применение |